{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:38:46Z","timestamp":1790487526150,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/bmt.2015.254","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T14:41:42Z","timestamp":1446475302000},"page":"432-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia\/lymphoma"],"prefix":"10.1038","volume":"51","author":[{"given":"S","family":"Haji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kiyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Suehiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shiratsuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Uike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"key":"BFbmt2015254_CR1","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007; 25: 5458\u20135464.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015254_CR2","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","volume":"116","author":"M Hishizawa","year":"2010","unstructured":"Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010; 116: 1369\u20131376.","journal-title":"Blood"},{"key":"BFbmt2015254_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bmt.2010.92","volume":"46","author":"I Choi","year":"2011","unstructured":"Choi I, Tanosaki R, Uike N, Utsunomiya A, Tomonaga M, Harada M et al. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials. Bone Marrow Transplant 2011; 46: 116\u2013118.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015254_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 2012; 30: 837\u2013842.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015254_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","volume":"169","author":"T Ishida","year":"2015","unstructured":"Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 2015; 169: 672\u2013682.","journal-title":"Br J Haematol"},{"key":"BFbmt2015254_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.194.6.847","volume":"194","author":"A Iellem","year":"2001","unstructured":"Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001; 194: 847\u2013853.","journal-title":"J Exp Med"},{"key":"BFbmt2015254_CR7","doi-asserted-by":"publisher","first-page":"e4420","DOI":"10.1371\/journal.pone.0004420","volume":"4","author":"L Ratner","year":"2009","unstructured":"Ratner L, Harrington W, Feng X, Grant C, Jacobson S, Noy A et al. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS One 2009; 4: e4420.","journal-title":"PLoS One"},{"key":"BFbmt2015254_CR8","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"AH Calvert","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7: 1748\u20131756.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015254_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000039746","volume":"104","author":"T Okamoto","year":"2000","unstructured":"Okamoto T, Nishimura Y, Yamada S, Yamada S, Itoh T, Mori A et al. Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma. Acta Haematol 2000; 104: 128\u2013130.","journal-title":"Acta Haematol"},{"key":"BFbmt2015254_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1084\/jem.20020399","volume":"196","author":"P Hoffmann","year":"2002","unstructured":"Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S . Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389\u2013399.","journal-title":"J Exp Med"},{"key":"BFbmt2015254_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbmt.2004.04.002","volume":"10","author":"PJ Martin","year":"2004","unstructured":"Martin PJ, Pei J, Gooley T, Anasetti C, Appelbaum FR, Deeg J et al. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. Biol Blood Marrow Transplant 2004; 10: 552\u2013560.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015254_CR12","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI41072","volume":"120","author":"K Matsuoka","year":"2010","unstructured":"Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest 2010; 120: 1479\u20131493.","journal-title":"J Clin Invest"},{"key":"BFbmt2015254_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12185-013-1387-8","volume":"98","author":"K Motohashi","year":"2013","unstructured":"Motohashi K, Suzuki T, Kishimoto K, Numata A, Nakajima Y, Tachibana T et al. Successful treatment of a patient with adult T cell leukemia\/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation. Int J Hematol 2013; 98: 258\u2013260.","journal-title":"Int J Hematol"},{"key":"BFbmt2015254_CR14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/bmt.2012.268","volume":"48","author":"Y Ito","year":"2013","unstructured":"Ito Y, Miyamoto T, Chong Y, Aoki T, Kato K, Akashi K et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia\/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant 2013; 48: 998\u2013999.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015254_CR15","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","volume":"119","author":"J Kanda","year":"2012","unstructured":"Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y et al. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood 2012; 119: 2141\u20132148.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015254","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:10:28Z","timestamp":1648059028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFbmt2015254"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.254","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]},"assertion":[{"value":"2 November 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}